MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Impact of Aquaporin-4 polymorphisms on Glymphatic Function and Motor Symptoms in Parkinson’s Disease

J. Qin, M. Zhang (Hangzhou, China)

Meeting: 2025 International Congress

Keywords: Parkinson’s

Category: Parkinson's disease: Neuroimaging

Objective: This study aims to investigate whether single-nucleotide polymorphisms (SNPs) of the Aquaporin-4(AQP4) gene were related to abnormal protein accumulation (α-synuclein), glymphatic dysfunction (DTI-ALPS), and motor symptoms in Parkinson’s disease patients.

Background: The glymphatic system is involved in clearing waste from the brain through aquaporin-4 (AQP4) water channels.

Method: A total of 136 newly diagnosed, drug-naive Parkinson’s disease patients at HY stage ≤ 2 were included in this study. Whole-genome sequencing data were analyzed. SNP pruning parameters were as follows: window size 10, increment 5, and variance inflation factor 2, resulting in a final set of 11 SNPs.[Figure1][Table1] TheDTI analysis along the perivascular space (DTI-ALPS) index was computed to evaluate glymphatic function by measuring the diffusivity of water molecules in the direction of the PVS1.[Figure2]

Linear regression models were independently applied to examine the association between AQP4 genotype and CSF α- synuclein, DTI-ALPS index, and UPDRS-III score, adjusting age, sex, and disease duration and educational level . A partial correlation analysis was conducted to explore the association between the DTI-ALPS index and UPDRS-III scores. Furthermore, we examined whether AQP4 genotypes moderate the relationship between DTI-ALPS and UPDRS-III scores.

Results: AQP4-rs1058427 was associated with a lower DTI-ALPS index (β = -0.07, p = 0.04), while AQP4- rs7240333 was linked to higher UPDRS-III scores (β = 5.19, p < 0.01). A significant negative correlation was observed between the DTI-ALPS index and UPDRS-III scores (r = -0.23, p < 0.01)[Figure3]. The effect of DTI-ALPS on UPDRS-III scores differs depending on the AQP4-rs1058427 status[Figure4]. Specifically, the negative association between DTI-ALPS and UPDRS-III scores was stronger in individuals with the rs1058427_HET genotype.(β = -26.33, p < 0.01).

Conclusion: 1.This study suggests that specific genetic variations of AQP4 are associated with glymphatic dysfunction and motor symptom severity in Parkinson’s disease, while no significant relationship was found with CSF α-synuclein accumulation. 2.The rs1058427_HET genotype moderates the effect of glymphatic dysfunction on motor symptoms, indicating a potential genetic influence the clinical manifestations of Parkinson’s disease.

FIgure1

FIgure1

Table1

Table1

Figure2

Figure2

Figure3

Figure3

Figure4

Figure4

To cite this abstract in AMA style:

J. Qin, M. Zhang. Impact of Aquaporin-4 polymorphisms on Glymphatic Function and Motor Symptoms in Parkinson’s Disease [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/impact-of-aquaporin-4-polymorphisms-on-glymphatic-function-and-motor-symptoms-in-parkinsons-disease/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/impact-of-aquaporin-4-polymorphisms-on-glymphatic-function-and-motor-symptoms-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley